US Bancorp’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.92K | Buy |
484
+15
| +3% | +$121 | ﹤0.01% | 3703 |
|
2025
Q1 | $3.93K | Buy |
469
+197
| +72% | +$1.65K | ﹤0.01% | 3709 |
|
2024
Q4 | $2.15K | Buy |
272
+118
| +77% | +$934 | ﹤0.01% | 3837 |
|
2024
Q3 | $1.28K | Hold |
154
| – | – | ﹤0.01% | 3841 |
|
2024
Q2 | $978 | Hold |
154
| – | – | ﹤0.01% | 3792 |
|
2024
Q1 | $933 | Sell |
154
-443
| -74% | -$2.68K | ﹤0.01% | 3807 |
|
2023
Q4 | $3.62K | Buy |
597
+494
| +480% | +$3K | ﹤0.01% | 3592 |
|
2023
Q3 | $435 | Sell |
103
-1,682
| -94% | -$7.1K | ﹤0.01% | 3835 |
|
2023
Q2 | $5.53K | Buy |
1,785
+458
| +35% | +$1.42K | ﹤0.01% | 3424 |
|
2023
Q1 | $1.85K | Hold |
1,327
| – | – | ﹤0.01% | 3753 |
|
2022
Q4 | $2.64K | Buy |
1,327
+1,209
| +1,025% | +$2.41K | ﹤0.01% | 3683 |
|
2022
Q3 | $0 | Sell |
118
-5,815
| -98% | – | ﹤0.01% | 4027 |
|
2022
Q2 | $19K | Buy |
5,933
+5,111
| +622% | +$16.4K | ﹤0.01% | 3048 |
|
2022
Q1 | $3K | Sell |
822
-59
| -7% | -$215 | ﹤0.01% | 3686 |
|
2021
Q4 | $4K | Sell |
881
-308
| -26% | -$1.4K | ﹤0.01% | 3662 |
|
2021
Q3 | $7K | Buy |
1,189
+116
| +11% | +$683 | ﹤0.01% | 3515 |
|
2021
Q2 | $5K | Sell |
1,073
-368
| -26% | -$1.72K | ﹤0.01% | 3575 |
|
2021
Q1 | $10K | Buy |
1,441
+619
| +75% | +$4.3K | ﹤0.01% | 3256 |
|
2020
Q4 | $4K | Hold |
822
| – | – | ﹤0.01% | 3401 |
|
2020
Q3 | $3K | Sell |
822
-1,500
| -65% | -$5.47K | ﹤0.01% | 3328 |
|
2020
Q2 | $11K | Hold |
2,322
| – | – | ﹤0.01% | 2993 |
|
2020
Q1 | $8K | Buy |
2,322
+1,830
| +372% | +$6.31K | ﹤0.01% | 3012 |
|
2019
Q4 | $2K | Sell |
492
-142
| -22% | -$577 | ﹤0.01% | 3396 |
|
2019
Q3 | $2K | Buy |
634
+492
| +346% | +$1.55K | ﹤0.01% | 3392 |
|
2019
Q2 | $1K | Sell |
142
-1,610
| -92% | -$11.3K | ﹤0.01% | 3527 |
|
2019
Q1 | $25K | Buy |
1,752
+105
| +6% | +$1.5K | ﹤0.01% | 2768 |
|
2018
Q4 | $22K | Sell |
1,647
-247
| -13% | -$3.3K | ﹤0.01% | 2775 |
|
2018
Q3 | $42K | Buy |
1,894
+18
| +1% | +$399 | ﹤0.01% | 2643 |
|
2018
Q2 | $31K | Buy |
+1,876
| New | +$31K | ﹤0.01% | 2782 |
|